Home > Boards > US Listed > Biotechs >

BioMarin Pharmaceutical Inc. (BMRN)

Add BMRN Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/4/2019 8:44:13 AM - Followers: 13 - Board type: Free - Posts Today: 0



BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Its product portfolio comprises approved products and multiple investigational product candidates. The company?s approved products include Naglazyme (galsulfase), a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used to treat genetic disease called mucopolysaccharidosis (MPS)VI; Kuvan (sapropterin dihydrochloride), a proprietary synthetic oral form of 6R-BH4, a naturally occurring enzyme co-factor for phenylalanine hydroxylase indicated for patients with Phenylketonuria (PKU); and Aldurazyme (laronidase) that is used to treat mucopolysaccharidosis I caused by the deficiency of a lysosomal enzyme called alpha-L-iduronidase. Its clinical development products comprise various product candidates for the treatment of genetic diseases, which include PEG-PAL, an enzyme substitution therapy under Phase I clinical development to treat phenylketonurics, which are not responsive to Kuvan; 6R-BH4, a Phase II clinical development product for the treatment of multiple cardiovascular indications, including sickle cell disease; and GALNS, an enzyme replacement therapy for MPS Type IV or Morquio Syndrome Type A (MPS IV A), a lysosomal storage disease. In addition, the company is conducting preclinical development of various other enzyme product candidates for genetic and other diseases, including a small molecule for the treatment of Duchenne muscular dystrophy. Further, BioMarin holds rights to receive royalties related to Orapred and Orapred ODT as a result of sublicense of North American rights. The company sells its products to specialty pharmacies, hospitals acting as retailers, and pharmaceutical wholesalers in the United States, Europe, and internationally. It has a strategic alliance with Merck Serono S.A. and joint venture with Genzyme Corporation. The company was founded in 1996 and is headquartered in Novato, California.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMRN News: BioMarin to Participate in 2019 RBC Capital Markets Global Healthcare Conference on May 21 in New York City 05/16/2019 08:30:00 AM
BMRN News: Statement of Changes in Beneficial Ownership (4) 05/14/2019 07:16:03 PM
BMRN News: Statement of Changes in Beneficial Ownership (4) 05/13/2019 07:09:08 PM
BMRN News: BioMarin to Participate in Bank of America Merrill Lynch Health Care Conference on May 15 in Las Vegas 05/08/2019 08:30:00 AM
BMRN News: European Commission Approves Palynziq® (pegvaliase injection) for Treatment of Phenylketonuria (PKU) in Patients Aged 16 Yea... 05/06/2019 10:12:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#676   Experiments in juveniles and infants can garner public MedResCollab 02/04/19 08:44:12 AM
#675   Two catalysts this month for BMRN. TradersFish 05/05/18 11:33:32 PM
#674   Out @ $88.50 for a small profit after chmcnfunds 08/30/17 01:43:23 PM
#673   very nice move off of the bottom here. Ole Broke Azz 08/30/17 01:36:15 PM
#672   According to WhaleWisdom, BMRN is Baker Bro 6th chmcnfunds 08/15/17 10:20:00 AM
#671   Sarepta Therapeutics and BioMarin Pharmaceutical Inc. Announce Execution chmcnfunds 07/18/17 09:13:21 AM
#670   Wrong choice. Hugh volume today and now near chmcnfunds 07/17/17 01:57:22 PM
#669   In BMRN @ $88.80 today. Hadn't traded it chmcnfunds 07/17/17 12:00:53 PM
#668   https://seekingalpha.com/article/4087040-biomarin-hemophila-candidates-looks-imp Inoviorulez 07/11/17 05:15:38 PM
#667   Always good to see the bulls. K The New Investor 08/25/16 11:56:12 AM
#666   BMRN bullish 91.99 stocktrademan 08/19/16 04:12:47 PM
#665   FDA denied BMRN. SRPT is leading now. IPO$ 08/11/16 10:28:30 AM
#664   BioMarin, Sarepta’s Loss Could Be PTC Therapeutic’s Gain venturecapp 01/18/16 12:12:48 PM
#663   Could the FDA Approve Both BioMarin and Sarepta’s trendmkr 12/17/15 02:09:43 PM
#662   Two Stocks to Watch This Month in Biotech trendmkr 12/03/15 01:28:09 PM
#661   Surprised to see you here. Bio-Marin is heading AliEn BRaInZ stox 11/29/15 12:15:11 PM
#660   Looks like we're all going to be on sunspotter 11/24/15 07:30:31 AM
#659   BMRN W TREND1 07/22/15 03:48:10 PM
#658   Inst % Owned = 99% TREND1 07/17/15 01:10:51 PM
#657   Now in regards to this, I would think KingDMC 07/17/15 10:40:15 AM
#656   Thank you KingDMC 07/17/15 10:39:33 AM
#655   King I think you are one of the TREND1 07/17/15 08:58:53 AM
#654   You'll find that I'm not a dumb retail KingDMC 07/17/15 08:50:45 AM
#653   KING Interesting how we find the same stocks. TREND1 07/16/15 11:07:58 PM
#652   BMRN W TREND1 07/16/15 11:06:00 PM
#651   Deutsche, Jeffries, Barclays $156 PT this morning. KingDMC 06/18/15 09:12:09 AM
#650   $BMRN DD Notes ~ http://www.ddnotesmaker.com/BMRN stocktrademan 09/26/14 01:48:57 PM
#649   Don't have PM and haven't been following BioMarin chmcnfunds 07/30/14 10:41:36 AM
#648   Great company. If you are in over the chmcnfunds 02/18/14 08:59:42 AM
#647   BioMarin Announces FDA Approval for VIMIZIM(TM) (elosulfase alfa) [SMART MONEY] 02/17/14 06:34:49 AM
#646   Not that I believe the BMRN drug would ghmm 01/02/14 06:21:15 PM
#645   Direct link to the briefing materials: chmcnfunds 11/15/13 10:00:57 AM
#644   FDA Posts Briefing Documents for Advisory Committee Meeting chmcnfunds 11/15/13 09:39:34 AM
#643   BioMarin Announces French ATU Granted for Vimizim(TM) for chmcnfunds 11/15/13 08:32:12 AM
#642   MACD crosses over and SAR flips today: chmcnfunds 11/13/13 10:22:56 AM
#641   Discussion in recent increase in shorts: chmcnfunds 11/13/13 07:33:27 AM
#640   Whomever purchased the big block is currently down chmcnfunds 11/12/13 11:32:39 AM
#639   AstraZeneca added 14p to £32.92 as it announced chmcnfunds 11/12/13 10:03:29 AM
#638   400,000 share purchase just made @ $62.00 (8:31:58 chmcnfunds 11/12/13 08:51:49 AM
#637   Thanks -- great find. Need a moderator to chmcnfunds 11/11/13 03:25:08 PM
#636   It looks like there will be a free ghmm 11/11/13 02:47:54 PM
#635   ghmm, I haven't seen anything about a webcast. chmcnfunds 11/11/13 02:41:39 PM
#634   Do you (or anyone) know if their will ghmm 11/11/13 01:53:11 PM
#633   A little over a week away: chmcnfunds 11/11/13 01:51:14 PM
#632   BioMarin Begins Phase 3 Trial Of BMN 673 chmcnfunds 10/31/13 11:42:30 AM
#631   From Sheff: chmcnfunds 10/29/13 03:10:23 PM
#630   Biotechs With FDA Review Dates In November 2013 chmcnfunds 10/25/13 02:00:23 PM
#629   Sell-side adjusts BioMarin targets after earnings • 11:15 AM chmcnfunds 10/25/13 01:15:16 PM
#628   Roche talks rare diseases, won't comment on Alexion, chmcnfunds 10/23/13 11:57:47 AM
#627   Roche talks rare diseases, won't comment on Alexion, chmcnfunds 10/23/13 11:57:47 AM